| 000 | 00993 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514010941.0 | ||
| 264 | 0 | _c20010927 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)71430-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFisken, R A | |
| 245 | 0 | 0 |
_aVitamin K in anticoagulation therapy. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 2001 |
||
| 300 |
_a637-8; author reply 638 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVitamin K _xadministration & dosage |
| 700 | 1 | _aBhatt, B M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 357 _gno. 9256 _gp. 637-8; author reply 638 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)71430-6 _zAvailable from publisher's website |
| 999 |
_c11480696 _d11480696 |
||